Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy
PurposeThe primary objective was to establish whether blood-based leucine-rich alpha-2-glycoprotein (LRG1) can predict outcomes in patients with locally advanced prostate cancer undergoing androgen-deprivation therapy (ADT) and radiotherapy (RT) and to determine how it may relate to 92 immune-oncolo...
Main Authors: | Guldvik, IJ, Ramberg, H, Kristensen, G, Røder, A, Mills, IG, Lilleby, W, Taskén, KA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer
2024
|
Similar Items
-
Radiotherapy and theranostics: a Lancet Oncology Commission
by: Abdel-Wahab, M, et al.
Published: (2024) -
A Digital Phenotypic Assessment in Neuro-Oncology (DANO): A Pilot Study on Sociability Changes in Patients Undergoing Treatment for Brain Malignancies
by: Siddi, Francesca, et al.
Published: (2025) -
Theranostics for neuroblastoma: making molecular radiotherapy work better
by: Gawne, PJ, et al.
Published: (2025) -
Prepayment meters strongly associated with multiple types of deprivation and emergency respiratory hospital admissions: an observational, cross-sectional study
by: Ding, X, et al.
Published: (2023) -
The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men
by: Chiu, Peter K. F., et al.
Published: (2024)